Advertisement

Antitumor Effect of Ganoderma (Lingzhi) Mediated by Immunological Mechanism and Its Clinical Application

  • Zhibin LinEmail author
  • Lixin Sun
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1182)

Abstract

The antitumor effect of Ganoderma (Lingzhi) is closely related to immunoregulation. Based on our research and other references, this article discussed the antitumor effect of Ganoderma mediated by immunological mechanism, including promoting the function of mononuclear-macrophages and natural killers; promoting M1-type macrophage polarization vs M2-type; promoting maturation and differentiation of dendritic cells, increasing its antigen presentation, activating lymphocytes and increasing cytotoxicity of cytotoxin T lymphocyte; promoting production of cytokines; and inhibiting tumor escape from immune surveillance. Also, clinical studies with immunological indexes were reviewed.

Keywords

Ganoderma Lingzhi Polysaccharides Triterpenes Immune Tumor 

References

  1. 1.
    Lin ZB (2015) Chapter 1. Historical data of Chinese Ganoderma (Lingzhi) research. In: Lin ZB (ed) Modern research on Ganoderma (Lingzhi), 4th edn. Peking University Medical Press, Beijing, pp 1–7Google Scholar
  2. 2.
    Wang SZ, Chen RY (2015) Chapter 7. Chemical components of Ganoderma (Lingzhi). In: Lin ZB (ed) Modern research on Ganoderma (Lingzhi), 4th edn. Peking University Medical Press, Beijing, pp 129–221Google Scholar
  3. 3.
    Lin ZB, Wang X (2015) Chapter 8: Pharmacological effects of Ganoderma (Lingzhi) (I). In: Lin ZB (ed) Modern research on Ganoderma (Lingzhi), 4th edn. Peking University Medical Press, Beijing, pp 129–221Google Scholar
  4. 4.
    Chui XY, Zhang YH, Yang BX, Zhang GL, Li WD, Lin ZB (2015) Chapter 9: Pharmacological effects of Ganoderma (Lingzhi) (II). In: Lin ZB (ed) Modern Research on Ganoderma (Lingzhi), 4th edn. Peking University Medical Press, Beijing, pp 300–374Google Scholar
  5. 5.
    Lin ZB (2015) Chapter 10: Clinical application of Ganoderma (Lingzhi). In: Lin ZB (ed) Modern research on Ganoderma (Lingzhi), 4th edn. Peking University Medical Press, Beijing, pp 398–431Google Scholar
  6. 6.
    Ito H, Naruse S, Shimura K (1977) Studies on antitumor activity of basidiomycete polysaccharides:VII. Antitumor effect of the polysaccharide preparation from Ganoderma lucidum on mouse sarcoma180. Mie Med J 26:147–152Google Scholar
  7. 7.
    Kin BK, Chung HS, Chung KS, Yang MS (1980) Studies on the antineoplastic components of Korea basidiomycetes. Hanguk KyunhakhoeChi 8(2):107–113Google Scholar
  8. 8.
    Miyazaki T, Nishijima M (1981) Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull (Tokyo) 29(12):3611–3612CrossRefGoogle Scholar
  9. 9.
    Mizuno T, Kato N, Totsuka, Tacanaka K, Shikai K, Shmizu M (1984) Fractionation, structural features and antitumor activity of water-soluble polysaccharide from ″Reishi″, the fruiting body of Ganoderma lucidum. Nippon Nogei Kagaku Kaishi 58:871–880CrossRefGoogle Scholar
  10. 10.
    Mizuno T, Suzuki E, Maki K, Tamaki H (1985) Fractionation, chemical modification and antitumor activity of water-in soluble polysaccharides of the fruiting body of Ganoderma lucidum. Nippon Nogei Kagaku Kaishi 59:1143–1151CrossRefGoogle Scholar
  11. 11.
    Lee SS, Chen FD, Chang SC, Wei YH, Liu I, Chen CF (1984) In vivo antitumor effect of crude extracts from the mycelium of Ganoderma lucidum. J Chin Oncol 5(3):22–28Google Scholar
  12. 12.
    Sone Y, Okuda R, Wada N, Kishida E, Misaki A (1985) Structures and antitumor activities of the polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agric Biol Chem 49(9):2641–2653Google Scholar
  13. 13.
    Maruyama H, Yamazaki K, Murofushi S, Konda C, Ikekawa T (1989) Antitumor activity of Sarcodon aspratus(Berk.)S. Ito and Ganoderma lucidum(Fr.)Karst. J Pharmacobiodyn 12(2):118–123PubMedCrossRefGoogle Scholar
  14. 14.
    Furusawa E, Chou SC, Furasawa S, Hirazum A, Dang Y (1992) Antitumor activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in synergenic mice. Phytother Res 6:300–304CrossRefGoogle Scholar
  15. 15.
    Ma L, Lin ZB (1995) Antitumor effects of Ganoderma lucidum polysaccharide peptide. Acta Pharmacol Sin 16:78–79Google Scholar
  16. 16.
    Cao QZ, Lin ZB (2004) Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol Sin 25(6):833–888PubMedPubMedCentralGoogle Scholar
  17. 17.
    Lin ZB, Zhang HN (2004) Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 25(11):1387–1395Google Scholar
  18. 18.
    Zhang QH, Yu DH, Lin ZB (2000) Study on the antitumor mechanism of Ganoderma lucidum extract(GLE)by serologic pharmacological method. J Beijing Med Univ 32(3):210–213Google Scholar
  19. 19.
    Zhang QH, Lin ZB (1999) Study on antitumor activity and mechanism of Ganoderma polysaccharides B. Chin J Integr Tradit West Med 19(9):544–547Google Scholar
  20. 20.
    Zhang QH, Lin ZB (1999) The antitumor activity of Ganoderma lucidum(Curt.:Fr.)P. Karst.(Lingzhi)(Aphyllophormycetideae)polysaccharides is related to tumor necrosis factor-α and interferon-γ. Int J Med Mushroom 1:207–215CrossRefGoogle Scholar
  21. 21.
    Hu YH, Lin ZB (1999) Effects of polysaccharides isolated from mycelia of Ganoderma lucidum on HL-60 cell apoptosis. Acta Pharm Sin 34(4):268–271Google Scholar
  22. 22.
    Hu YH, Lin ZB, He YQ, Zhao CJ (1999) Polysaccharides isolated from mycelia of Ganoderma lucidum induced on HL- 60 cell apoptosis by enhancing macrophage activity. Chin Pharmacol Bul 15(1):27–30Google Scholar
  23. 23.
    Wang SY, Hsu ML, Hsu HC, Tzeng CH, Lee SS, Shiao MS (1997) The anti- tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 70(6):699–705PubMedCrossRefGoogle Scholar
  24. 24.
    Li MC, Lei LS, Liang DS, Xu ZM, Yang SQ, Sun LS (2000) Effect of Ganoderma polysaccharides on interleukin 1α and tumor necrosis factor α mRNA expression in murine peritoneal macrophages. Chin J Pharmacol Toxicol 14(3):237–240Google Scholar
  25. 25.
    Wang PY, Zhu XL, Lin ZB (2012) Antitumor and immunomodulatory effects of polysaccharides from broken-spore of Ganoderma lucidum. Front Pharmacol 3:135PubMedPubMedCentralGoogle Scholar
  26. 26.
    Su J, Su L, Li D, Shuai O, Zhang Y, Liang H, Jiao C, Xu Z, Lai Y, Xie Y (2018) Antitumor activity of extract from the sporoderm-breaking spore of Ganoderma lucidum: restoration on exhausted cytotoxic T cell with gut microbiota remodeling. Front Immunol 9:1765.  https://doi.org/10.3389/fimmu.2018.01765 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Zhao R, Chen Q, He Y-m (2018) The effect of Ganoderma lucidum extract on immunological function and identify its anti-tumor immunostimulatory activity based on the biological network. Sci Rep 8:12680.  https://doi.org/10.1038/s41598-018-30881-0 CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Wang CH, Shi SS, Chen Q, Lin SQ, Wang R, Wang SZ, Chen CM (2018) Antitumor and immunomodulatory activities of Ganoderma lucidum polysaccharides in glioma-bearing rats. Integr Cancer Ther 17(3):674–683PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Cao LZ, Lin ZB (2002) Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol Lett 83(3):163–169PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Cao LZ, Lin ZB (2003) Regulatory effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro. Acta Pharmacol Sin 24(4):321–322PubMedGoogle Scholar
  31. 31.
    Lin YL, Liang YC, Lee SS, Chiang BL (2005) Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte derived dendritic cells by the NF-kappa B and p38 mitogen- activated protein kinase pathways. J Leukoc Biol 78(2):533–543PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Lin YL, Liang YC, Tseng YS, Huang HY, Chou SY, Hseu RS, Huang CT, Chiang BL (2009) An immunomodulatory protein, Ling Zhi- 8, induced activation and maturation of human monocyte-derived dendritic cells by the NF- kappa B and MAPK pathways. J Leukoc Biol 86(4):877–889PubMedCrossRefGoogle Scholar
  33. 33.
    Chan WK, Law HK, Lin ZB, Lau YL, Chan GC (2007) Response of human dendritic cells to different immunomodulatory polysaccharides derived from mushroom and barley. Int Immunol 19(7):891–899PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Chan WK, Cheung CC, Law HK, Lau YL, Chan GC (2008) Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function. J Hematol Oncol 1:9PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Meng J, Hu X, Shan F, Hua H, Lu C, Wang E et al (2011) Analysis of maturation of murine dendritic cells (DCs) induced by purified Ganoderma lucidum polysaccharides (GLPs). Int J Biol Macromol 49(4):693–699CrossRefGoogle Scholar
  36. 36.
    Yoshida H, Suzuki M, Sakaguchi R, Tani I, Kotani H, Shudo N, Yoshimura A (2012) Preferential induction of Th17 cells in vitro and in vivo by Fucogalactan from Ganoderma lucidum (Reishi). Biochem Biophys Res Commun 422(1):174–180PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Yue GG, Chan BC, Han XQ, Cheng L, Wong EC, Leung PC, Fung KP, Ng MC, Fan K, Sze DM, Lau CB (2013) Immunomodulatory activities of Ganoderma sinense polysaccharides in human immune cells. Nutr Cancer 65(5):765–774PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Zhang SL, Chen C, Qin JZ, Yu H, Liu YM, Zhang XH, Song ZT, Zhao J, Wang FJ, Wang YY, Zhang LW (2019) Effective cancer immunotherapy by Ganoderma lucidum polysaccharide-gold nanocomposites through dendritic cell activation and memory T cell response. Carbohydr Polym 205:192–202PubMedCrossRefGoogle Scholar
  39. 39.
    Lin ZB, Zhang ZL, Ruan Y, Wu YC, Cong Z (1980) The pharmacological study of Ganoderma lucidum partVI: effects of different extract fractions from Ganoderma lucidum fruiting bodies on the phagocytic activity of mouse peritoneal macrophages. Edib Fungi 3:5–2Google Scholar
  40. 40.
    Gao B, Yang GZ (1989) Effects of Ganoderma applanatum polysaccharides on immune function of normal mouse and its tumor inhibiting action. Chin J Immunol 5:363–362Google Scholar
  41. 41.
    Gu LG, Zhou Y, Yan XZ, Tao JD (1990) Effect of Ganoderma capense on macrophages in mice. Shanghai J Immunol 1(4):205–202Google Scholar
  42. 42.
    Cao LZ, Lin ZB (2003) Comparison of the effects of polysaccharides from wood-cultured and bag-cultured Ganoderma lucidum on murine spleen lymphocyte proliferation in vitro. Acta Pharm Sin 38(2):92–97Google Scholar
  43. 43.
    Tang QJ, Zhang JS, Pan YJ, Werner R, Fan H (2004) Activation of mouse macrophages by the alkali extracted polysaccharide from spore of Ganoderma lucidum. Chin J Cell Mol Immunol 20(2):142–144Google Scholar
  44. 44.
    Hsu MJ, Lee SS, Lee ST, Lin WW (2003) Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum. Br J Pharmacol 139(2):289–298PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Hsu MJ, Lee SS, Lin WW (2002) Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. J Leukoc Biol 72(1):207–212PubMedGoogle Scholar
  46. 46.
    Chien CM, Cheng JL, Chang WT, Tien MH, Tsao CM, Chang YH, Chang HY, Hsieh JF, Wong CH, Chen ST (2004) Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56 + NK- cell cytotoxicity in cord blood. Bioorg Med Chem 12(21):5603–5609PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Tang QJ, Zhang JS, Pan YJ, Martin ZK, Werner R, Fan H (2005) Activation of normal and tumor-bearing mouse macrophages by active polysaccharide from Ganoderma lucidum. Curr Immunol 25(1):49–52Google Scholar
  48. 48.
    Zhang J, Tang Q, Zhou C, Jia W, Da Silva L, Nguyen LD, Reutter W, Fan H (2010) GLIS a bioactive proteoglycan fraction from Ganoderma lucidum, displays antitumour activity by increasing both humoral and cellular immune response. Life Sci 87(19–22):628–637PubMedCrossRefGoogle Scholar
  49. 49.
    Wei MT, Hua KF, Hsu J, Karmenyan A, Tseng KY, Wong CH, Chiou A (2007) The interaction of lipopolysaccharide with membrane receptors on macrophages pretreated with extract of Reishi polysaccharides measured by optical tweezers. Opt Express 15(17):11020–11032PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Watanabe K, Shuto T, Sato M, Onuki K, Mizunoe S, Suzuki S, Sato T, Koga T, Suico MA, Kai H, Ikeda T (2011) Lucidenic acids-rich extract from antlered form of Ganoderma lucidum enhances TNFα induction in THP- 1 monocytic cells possibly via its modulation of MAP kinases p38 and JNK. Biochem Biophys Res Commun 408(1):18–24PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Zhang S, Nie S, Huang D, Li W, Xie M (2013) Immunomodulatory effect of Ganoderma atrum polysaccharide on CT26 tumor- bearing mice. Food Chem 136(3–4):1213–1219PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Huang JQ, Nie QX, Liu XZ, Zhang SS, Nie SP, Huang DF, Xie MY (2016) Ganoderma atrum polysaccharide modulates TNF-α secretion and mRNA expression in macrophages of S-180 tumor-bearing mice. Food Hydrocoll 53:24–30CrossRefGoogle Scholar
  53. 53.
    Chanmee T, Ontong P, Konno K, Itano N (2014) Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel) 6(3):1670–1690CrossRefGoogle Scholar
  54. 54.
    Sun L-X, Lin Z-B, Lu J, Li W-D, Niu Y-D, Yu S, Hu C-Y, Zhang G-Q, Duan X-S (2017) The improvement of M1 polarization in macrophages by glycopeptide derived from Ganoderma lucidum. Immunol Res.  https://doi.org/10.1007/s12026-017-8893-3 PubMedCrossRefGoogle Scholar
  55. 55.
    Wang W-J, Wu Y-S, Chen S, Liu C-F, Chen S-N (2015) Mushroom 𝛽-Glucan May immunomodulate the tumor-associated macrophages in the Lewis Lung Carcinoma. Bio Med Res Int 2015:604385, 15 pages.  https://doi.org/10.1155/2015/604385 CrossRefGoogle Scholar
  56. 56.
    Li MC, Lei LS, Liang DS, Xu ZM, Yang SQ, Sun LS (1999) Effect of Ganoderma polysaccharide on intracellular free calcium in murine peritoneal macrophages. Chin Pharm J 34(12):805–807Google Scholar
  57. 57.
    Li MC, Lei LS, Liang DS, Xu ZM, Yang SQ, Sun LS (2000) Effect of Ganoderma polysaccharides on PKC activity in murine peritoneal macrophages. Chin Pharmacol Bull 16(1):36–38Google Scholar
  58. 58.
    You YH, Lin ZB (2002) Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta Pharmacol Sin 23(9):787–791PubMedGoogle Scholar
  59. 59.
    You YH, Lin ZB (2004) Free radical scavenging activity by Ganoderma lucidum polysaccharides peptide on peritoneal macrophages in mice. Chin J Clin Pharmacol Ther 9(1):52–55Google Scholar
  60. 60.
    You YH, Lin ZB (2004) Influence of Ganoderma lucidum polysaccharides peptide on free-radical induced peritoneal macrophage injury in early stage. Chin J Pharmacol Toxicol 19(2):137–139Google Scholar
  61. 61.
    Cheng CH, Leung AY, Chen CF (2010) The effects of two different Ganoderma species (Lingzhi) on gene expression in human monocytic THP-1 cells. Nutr Cancer 62(5):648–658PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Won SJ, Lee SS, Ke YH et al (1989) Enhancement of splenic NK cytotoxic activity by extracts of Ganoderma lucidum mycelium in mice. J Biomed Lab Sci 2:201–213Google Scholar
  63. 63.
    Won SJ, Lin MT, Wu WL (1992) Ganoderma tsugae mycelium enhances splenic natural killer cell activity and serum interferon production in mice. Jpn J Pharmacol 59(2):171–172PubMedCrossRefGoogle Scholar
  64. 64.
    Ning AH, Cao J, Huag M, Zhang W (2004) The antitumor action and influence of immune systerm of Ganoderma polysaccharides in mice. Chin J Microecol 16(1):13–14Google Scholar
  65. 65.
    Zhu XL, Chen AF, Lin ZB (2007) Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol 11(2):219–222CrossRefGoogle Scholar
  66. 66.
    Chang YH, Yang JS, Yang JL, Wu CL, Chang SJ, Lu KW, Lin JJ, Hsia TC, Lin YT, Ho CC, Wood WG, Chung JG (2009) Ganoderma lucidum extracts inhibited leukemia WEHI-3 cells in BALB/c mice and promoted an immune response in vivo. Biosci Biotechnol Biochem 73(12):2589–2594PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Tsai CC, Yang FL, Huang ZY, Chen CS, Yang YL, Hua KF, Li J, Chen ST, Wu SH (2012) Oligosaccharide and peptidoglycan of Ganoderma lucidum activate the immune response in human mononuclear cells. J Agric Food Chem 60(11):2830–2837PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Zhu XL, Lin ZB (2005) Effects of Ganoderma lucidum polysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells. Acta Pharmacol Sin 26(9):1130–1137PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Zhu XL, Lin ZB (2006) Modulation of cytokines production granzyme B and perforin in murine CIK cells by Ganoderma lucidum polysaccharides. Carbohydr Polym 63:188–197CrossRefGoogle Scholar
  70. 70.
    Ochsenbein AF (2002) Principles of tumor immunosurveillance and implications for immunotherapy. Cancer Gene Ther 9(12):1043–1055PubMedCrossRefGoogle Scholar
  71. 71.
    Sun LX, Lin ZB, Li XJ, Li M, Lu J, Duan XS, Ge ZH, Song YX, Xing EH, Li WD (2011) Promoting effects of Ganoderma lucidum polysaccharides on B16F10 cells to activate lymphocytes. Basic Clin Pharmacol Toxicol 108(3):149–154CrossRefGoogle Scholar
  72. 72.
    Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li XF, Li XJ, Li M, Xing EH, Song YX, Jia J, Li WD (2012) Enhanced MHC class I and costimulatory molecules on B16F10 cells by Ganoderma lucidum polysaccharides. J Drug Target 20(7):582–592PubMedCrossRefGoogle Scholar
  73. 73.
    Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li XJ, Li M, Xing EH, Jia J, Lan TF, Li WD (2011) Ganoderma lucidum polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells. J Pharm Pharmacol 63(5):725–735PubMedCrossRefGoogle Scholar
  74. 74.
    Sun LX, Lin ZB, Duan XS, Qi HH, Yang N, Li M, Xing EH, Sun Y, Yu M, Li WD, Lu J (2014) Suppression of the production of transforming growth factor β1, interleukin-10, and vascular endothelial growth factor in the B16F10 cells by Ganoderma lucidum polysaccharides. J Interf Cytokine Res 34(9):667–675CrossRefGoogle Scholar
  75. 75.
    Sun LX, Li WD, Lin ZB, Duan XS, Xing EH, Jiang MM, Yang N, Qi HH, Sun Y, Li M, Niu YD, Lu J (2015) Cytokine production suppression by culture supernatant of B16F10 cells and amelioration by Ganoderma lucidum polysaccharides in activated lymphocytes. Cell Tissue Res 360(2):379–389PubMedCrossRefGoogle Scholar
  76. 76.
    Sun LX, Li WD, Lin ZB, Duan XS, Li XF, Yang N, Lan TF, Li M, Sun Y, Yu M, Lu J (2014) Protection against lung Cancer patient plasma-induced lymphocyte suppression by Ganoderma lucidum polysaccharides. Cell Physiol Biochem 33(2):289–299PubMedCrossRefGoogle Scholar
  77. 77.
    Lu J, Sun LX, Lin ZB, Duan XS, Ge ZH, Xing EH, Lan TF, Yang N, Li XJ, Li M, Li WD (2014) Antagonism by Ganoderma lucidum polysaccharides against the suppression by culture supernatants of B16F10 melanoma cells on macrophage. Phytother Res 28(2):200–202PubMedCrossRefGoogle Scholar
  78. 78.
    Liao SF, Liang CH, Ho MY, Hsu TL, Tsai TI, Hsieh YS, Tsai CM, Li ST, Cheng YY, Tsao SM, Lin TY, Lin ZY, Yang WB, Ren CT, Lin KI, Khoo KH, Lin CH, Hsu HY, Wu CY, Wong CH (2013) Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor- associated Globo H- series epitopes. Proc Natl Acad Sci U S A 110(34):13809–13814PubMedCentralCrossRefPubMedGoogle Scholar
  79. 79.
    Cong Z, Lin ZB (1981) The pharmacological study of Lingzhi(Ganoderma lucidum)and the research therapeutical principle of ″ Fuzhengguben″ in traditional Chinese medicine. J Beijing Med Coll 1(1):6–10Google Scholar
  80. 80.
    Lin ZB (2001) Integrated study with traditional and Western medicine on Ganoderma(Lingzhi)guided by theory TCM. Chin J Integr Tradit West Med 21(12):883–884Google Scholar
  81. 81.
    Lin ZB (2010) Fu Zhen Gu ben principle of Ganoderma (Lingzhi) explained by integrated study with traditional and Western medicine. J Fujian Univ of Tradit 20(6):1–2Google Scholar
  82. 82.
    Yan BK, Wei YJ, Li YQ (1998) Effect of Laojunxian Lingzhi Oral liquid combined with chemotherapy on non-parvicellular lung cancer at stages II and III. Tradit Chin Drug Res Clin Pharmacol 9(2):78–80Google Scholar
  83. 83.
    Zhang X, Jia YM, Li Q, Niu SF, Zhu SN, Shen CF (2000) Clinical curative effect investigation of Lingzhi tablets on lung cancer. Chin Tradit Pat Med 22(7):486–588Google Scholar
  84. 84.
    Wang YH, Qu ZH, Zhao ZY (2014) Effect of Ganoderma lucidum spores on immune function in patients with non small cell lung cancer during chemotherapy. China Pract Med 9(23):20–21Google Scholar
  85. 85.
    Lin ND, Su JN, Zhu Z, Gao YH, Gao H, Xie GY (2004) Analysis on 66 cases of cancer patients treated by chemotherapy with extract of Ganoderma lucidum. J Pract Tradit Chin Intern Med 18(5):457–458Google Scholar
  86. 86.
    Qi YF, Li XR, Yan M, Liu A, Jiao ZH, Liu Y (1999) Clinical observation of adjuvant chemotherapy by Ganoderma lucidum spore for the treatment of digestive tract cancer patients. Chin J I Integr Tradit West Med 19(9):554–555Google Scholar
  87. 87.
    Zhen ZJ, Chen YJ, Yong JI, Wang FJ, Li JY, Li QH, Wu ZP, Fan GY (2012) Inhibitory efficacy of Ganoderma lucidum spore on recurrence after curative resection of hepatocellular carcinoma. J Dig Oncol (Electron Version) 4(1):40–43Google Scholar
  88. 88.
    Zhen ZJ, Wang FJ, Fan GY, Chen HW (2013) Effect of Ganoderma lucidum spore to the immunological function of patients with hepatocellular carcinoma after operation. Chin J Hepat Surg (Electron Ed) 2(3):171–174Google Scholar
  89. 89.
    Zhou JH, Zhang QH (2014) Effect of Ganoderma lucidum spore on T cell subtype and VEGF of peripheral blood in old patients with carcinoma of uterine cervix. Matern Child Health Care China 29(13):2021–2022Google Scholar
  90. 90.
    Zhao H, Zhang Q, Zhao L, Huang X, Wang J, Kang X (2012) Spore powder of Ganoderma lucidum improves cancer- related fatigue in breast cancer patients undergoing endocrine therapy:a pilot clinical trial. Evid Based Complement Alternat Med 2012:809614, 8 pages.  https://doi.org/10.1155/2012/809614 CrossRefPubMedGoogle Scholar
  91. 91.
    Jin X, Ruiz Beguerie J, Sze DM, Chan GC (2016) Cochrane Database Syst Rev 4:CD007731.  https://doi.org/10.1002/14651858.CD007731.pub3 CrossRefPubMedGoogle Scholar
  92. 92.
    Santesso N, MLIS, Wieland LS, MPH (2016) A summary of a Cochrane review: Ganoderma lucidum (Reishi mushroom) for the treatment of cancer. Eur J Integr Med 8:619–620PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Cao QZ, Lin ZB (2006) Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci 78(13):1457–1463PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Wang XJ, Xu JP, Cheng YF (2006) Inhibitory and antiangiogenetic effects of Ganoderma Lucidum spore on the human hepatocarcinoma transplanted in nude mice. Acta Acad Med Xuzhou 26(2):115–119Google Scholar
  95. 95.
    Hsu SC, Ou CC, Chuang TC, Li JW, Lee YJ, Wang V, Liu JY, Chen CS, Lin SC, Kao MC (2009) Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells:In vitro and in vivo. Cancer Lett 281(1):108–112PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Guo PR, Sheng YW, Liu B, Wang C, Liu YD, Fu DW et al (2014) Influence of Ganoderma lucidum polysaccharide on the inhibitory effects of cisplatin on the tumor growth and angiogenesis in bladder cancer(T24)cells-bearing nude mice. Med J Chin PLA 9(6):470–474Google Scholar
  97. 97.
    Kimura Y, Taniguchi M, Baba K (2002) Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res 22(6A):3309–3318PubMedPubMedCentralGoogle Scholar
  98. 98.
    Song YS, Kim SH, Sa JH, Jin C, Lim CJ, Park EH (2004) Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. J Ethnopharmacol 90(1):17–20PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    Zhang XC, Chen GL, Ma B, Li XJ, Yu HM (2005) Ganoderma lucidum polysaccharides inhibit angiogenesis and cell adhesion in chicken chorioallantoic membrane model. Basic Clin Med 25(9):825–828Google Scholar
  100. 100.
    Qi ZH, Meng J, Wang ZL, Sun HZ, Yang G (2016) Antitumor effect of Ganoderma lipsiense extract on triple-negative breast Cancer model mice and mechanism study. Chin J Integr Tradit West Med 36(3):366–369Google Scholar
  101. 101.
    Sliva D, Sedlak M, Slivova V, Valachovicova T, Lloyd FP Jr, Ho NW (2003) Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Complement Med 9(4):491–497PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd FP Jr, Ho NW (2002) Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 298(4):603–612CrossRefGoogle Scholar
  103. 103.
    Cao QZ, Lin SQ, Wang SZ, Lin ZB (2007) Effect of Ganoderma lucidum polysaccharides peptide on invasion of human lung carcinoma cells in vitro. J Peking Univ(Health Sci) 39(6):653–652Google Scholar
  104. 104.
    Zhao SF, Luo B, Cheng JX (2010) Effect of Ganoderma lucidum spore on invasion and metastasis of human ovarian carcinoma cells. Chin J Basic Med Tradit Chin Med 16(6):524–526Google Scholar
  105. 105.
    Li WD, Zhang BD, Wei R, Liu JH, Lin ZB (2008) Reversal effect of Ganoderma lucidum polysaccharide on multidrug resistance in K562/ADM cell line. Acta Pharmacol Sin 29(5):620–627PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Sadava D, Still DW, Mudry RR, Kane SE (2009) Effect of Ganoderma on drug-sensitive and multidrug resistant small-cell lung carcinoma cells. Cancer Lett 277(2):182–189PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Tang W (2013) Ganoderic acid T improves sensitivity of multidrug resistant KB-A-1/Dox cells to doxorubicin. Nat Prod Res Dev 25:1052–1055Google Scholar
  108. 108.
    Tang Y, Gao QH, Xu WT, Wu Z, Li FR (2013) Study of Ganoderma lucidum on active component reversed SGC7901/ADR multidrug resistance. J Chin Med Mater 36(1):2007–2010Google Scholar
  109. 109.
    Chung WT, Lee SH, Kim JD, Park YS, Hwang B, Lee SY, Lee HY (2001) Effect of mycelial culture broth of Ganoderma lucidum on the growth characteristics of human cell lines. J Biosci Bioeng 92(6):550–555PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Gao JJ, Min BS, Ahn EM, Nakamura N, Lee HK, Hattori M (2002) New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem Pharm Bull(Tokyo) 50(6):837–840CrossRefGoogle Scholar
  111. 111.
    Min BS, Gao JJ, Nakamura N, Hattori M (2000) Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth- A and LLC tumor cells. Chem Pharm Bull (Tokyo) 48(7):1026–1033PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Su HJ, Fann YF, Chung MI, Won SJ, Lin CN (2000) New lanostanoids of Ganoderma tsugae. J Nat Prod 63(4):514–512Google Scholar
  113. 113.
    Müller CI, Kumagai T, O’Kelly J, Seeram NP, Heber D, Koeffler HP (2006) Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res 30(7):841–848CrossRefGoogle Scholar
  114. 114.
    Ruan WW, Popovich DG (2012) Ganoderma lucidum triterpenoid extract induces apoptosis in human colon carcinoma cells(Caco- 2). Biomed Prev Nutr 2(3):203–209CrossRefGoogle Scholar
  115. 115.
    Calviño E, Pajuelo L, Manjón JL, Sancho P, Tejedor MC, Gil J et al (2012) Active fraction from Ganoderma lucidum with apoptosis activity on peripheral blood mononuclear cells from chronic lymphocytic leukemia. Eur J Integr Med 4(3):e335–e343CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Pharmacology, School of Basic Medical SciencesPeking UniversityBeijingChina
  2. 2.Affiliated Hospital of Chengde Medical UniversityChengdeChina

Personalised recommendations